Literature DB >> 27475955

Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.

Guerry M Peavy1, Steven D Edland2, Belinda M Toole3, Lawrence A Hansen4, Douglas R Galasko5, Ann M Mayo3.   

Abstract

INTRODUCTION: The goal was to compare subgroups of dementia with Lewy Bodies (DLB) using neuropathological measures to differentiate 'pure' Lewy body (LB) dementia from 'mixed' DLB [co-occurring LB and Alzheimer's disease (AD) pathology] to facilitate diagnostic decision-making and future development of interventions based on predicted type(s) of neuropathology. Studies comparing these groups are rare relative to those differentiating 'pure' AD and all-cause DLB, and are limited by insufficient sample size, brief cognitive batteries, and/or absence of autopsy confirmation. To address these limitations, we assessed cognition and other features in a large, autopsy-confirmed DLB sample using an extensive neuropsychological battery.
METHODS: Subjects from an AD research center autopsy series satisfying DLB pathology criteria were divided by an AD neuropathology index into DLB-LB (Braak stage 0-3) (n = 38) and DLB-AD (Braak stage 4-6) (n = 41) and compared on baseline variables from chart reviews and standardized measures.
RESULTS: DLB-LB subjects were more impaired on visuospatial constructions, visual conceptual reasoning, and speed of processing, but less impaired on verbal memory and confrontation naming. All-type hallucinations occurred more frequently in DLB-LB, while delusions were common in both groups. Groups were similar in education and age at onset, and in baseline age, dementia severity, and functional capacity.
CONCLUSION: Salient findings included greater impairment on visual tasks and speed of processing and more frequent reports of all-type hallucinations in DLB-LB compared to DLB-AD. Relatively intact confrontation naming in DLB-LB and no differences in reported delusions were of note. Identifying differences in phenotypic features can improve prediction of underlying neuropathology.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Behavior; Delusions; Dementia with Lewy bodies; Hallucinations; Neuropsychology; Parkinsonism

Mesh:

Year:  2016        PMID: 27475955      PMCID: PMC5794000          DOI: 10.1016/j.parkreldis.2016.07.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

2.  An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

Authors:  I G McKeith; A F Fairbairn; R A Bothwell; P B Moore; I N Ferrier; P Thompson; R H Perry
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

3.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

4.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

Review 5.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

7.  A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Dean C Delis; Lawrence A Hansen; Eliezer Masliah; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2004-09       Impact factor: 2.892

8.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

Authors:  A R Merdes; L A Hansen; D V Jeste; D Galasko; C R Hofstetter; G J Ho; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

9.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

10.  Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease.

Authors:  D J Connor; D P Salmon; T J Sandy; D Galasko; L A Hansen; L J Thal
Journal:  Arch Neurol       Date:  1998-07
View more
  22 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 2.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

3.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

Authors:  David Coughlin; Sharon X Xie; Mendy Liang; Andrew Williams; Claire Peterson; Daniel Weintraub; Corey T McMillan; David A Wolk; Rizwan S Akhtar; Howard I Hurtig; H Branch Coslett; Roy H Hamilton; Andrew D Siderowf; John E Duda; Katya Rascovsky; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski; David J Irwin
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

4.  Associations among Braak stage, Parkinsonian gait, cognition, and functional status in autopsy-confirmed dementia with Lewy bodies.

Authors:  Ann M Mayo; Guerry M Peavy
Journal:  Int J Geriatr Psychiatry       Date:  2019-03-15       Impact factor: 3.485

Review 5.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Authors:  David G Coughlin; Howard I Hurtig; David J Irwin
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

6.  Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.

Authors:  Erica Howard; David J Irwin; Katya Rascovsky; Naomi Nevler; Sanjana Shellikeri; Thomas F Tropea; Meredith Spindler; Andres Deik; Alice Chen-Plotkin; Andrew Siderowf; Nabila Dahodwala; Daniel Weintraub; Leslie M Shaw; John Q Trojanowski; Sanjeev N Vaishnavi; David A Wolk; Dawn Mechanic-Hamilton; James F Morley; John E Duda; Murray Grossman; Katheryn A Q Cousins
Journal:  Neurology       Date:  2021-02-16       Impact factor: 9.910

7.  Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.

Authors:  D G Coughlin; R Ittyerah; C Peterson; J S Phillips; S Miller; K Rascovsky; D Weintraub; A D Siderowf; J E Duda; H I Hurtig; D A Wolk; C T McMillan; P A Yushkevich; M Grossman; E B Lee; J Q Trojanowski; D J Irwin
Journal:  Neuropathol Appl Neurobiol       Date:  2020-09-24       Impact factor: 8.090

8.  Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution.

Authors:  Tanis J Ferman; Naoya Aoki; Bradley F Boeve; Jeremiah A Aakre; Kejal Kantarci; Jonathan Graff-Radford; Joseph E Parisi; Jay A Van Gerpen; Neill R Graff-Radford; Ryan J Uitti; Otto Pedraza; Melissa E Murray; Zbigniew K Wszolek; R Ross Reichard; Julie A Fields; Owen A Ross; David S Knopman; Ronald C Petersen; Dennis W Dickson
Journal:  Neurology       Date:  2020-06-19       Impact factor: 9.910

9.  Sex differences for phenotype in pathologically defined dementia with Lewy bodies.

Authors:  Ece Bayram; David G Coughlin; Sarah J Banks; Irene Litvan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 10.154

10.  Multimodal in vivo and postmortem assessments of tau in Lewy body disorders.

Authors:  David G Coughlin; Jeffrey S Phillips; Emily Roll; Claire Peterson; Rebecca Lobrovich; Katya Rascovsky; Molly Ungrady; David A Wolk; Sandhitsu Das; Daniel Weintraub; Edward B Lee; John Q Trojanowski; Leslie M Shaw; Sanjeev Vaishnavi; Andrew Siderowf; Ilya M Nasrallah; David J Irwin; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2020-08-21       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.